Head of Investor Relations
Cecilia Ketels
cecilia.ketels@elekta.com
Q4 Earnings Call for investors and analysts
at 10am CEST on May 25
Dial-in details
UK: +44 333 300 9266
USA: +1 646 722 4903
Sweden: +46 8 505 583 73
Press
releases
May 18
The power of ‘seeing what you treat’ with Elekta Unity reported in 71 abstracts at ESTRO 2022
May 10
Kaiku Health enters a strategic partnership to further improve patient outcomes through digital patient monitoring
May 7
Elekta and the Netherlands Cancer Institute, co-develop the next generation of radiotherapy solutions
Upcoming
events
Q2 report
Annual General Meeting 2022
Q1 report
Annual Report 2021/22
Jefferies Healthcare Conference
Q4 roadshow, London
Q4 roadshow, Stockholm
Q4 and year-end report
ESTRO investor meeting, Copenhangen
Silent period prior to Q4 report
Jefferies Pan-European Mid-Cap Conference (virtual)
Oppenheim healthcare conference
Carnegie Nordic healthcare conference
Q3 roadshow, London
Q3 roadshow, US (digital)
Q3 roadshow, Stockholm
Q3 report
Silent period prior to Q3 report
JP Morgan healthcare conference (digital)
SEB Nordic seminar (digital)
Berenberg Conference (digital)
Danske Bank winter conference (digital)
Q2 road show, London (digital)
Q2 roadshow, Stockholm
Q2 report
Silent period prior to Q2 report
Q3 report
Our order growth confirms Elekta’s competitive offer, and our strong commitment to customers generates a strong platform for profitable growth going forward.
- Gustaf Salford, President and CEO
2022-02-24Interim report, May - January 2021/22
Key figures (rolling 12m)
Capital Markets Day
Our last capital markets day was held digitally on June 7, 2021.
Subscribe to press releases
